MARSEILLE, France—Trophos SA has announced a €6 million ($8.05 million) European Union award to support MitoCare, a two-and-a-half year international, translational medicine project involving a 16-partner consortium to be led by Trophos, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology

Ryan McBride 11/8/10 Framingham, MA-based GTC Biotherapeutics, the first company to get FDA approval of a drug derived from genetically modified animals, has struck a stock purchase and merger deal with LFB Biotechnologies, according to a press release. France’s LFB…

* Orexigen to get upfront cash payment of $50 mln
* Deal can pay Orexigen over $1 bln in milestone payments
* Takeda to market obesity drug in U.S., Mexico, Canada
* Cos to share costs of any future product development
* Orexigen shares jump 23 pct (Adds analyst comment, background, updates share price)

In a Video Game, Tackling the Complexities of Protein Folding In a match that pitted video game players against the best known computer program designed for the task, the gamers outperformed the software in figuring out how 10 proteins fold…